A San Diego Superior Court judge has ruled that Johnson & Johnson (J&J) should pay $344 million in damages after they deceptively marketed and misrepresented the risks of transvaginal pelvic mesh implants used to treat stress urinary incontinence and pelvic organ prolapse. J&J was accused of making false or misleading statements about the safety of vaginal-mesh products in magazine ads, on the internet and in brochures. The company also made thousands of sales calls where officials deceived doctors in regards to the risks of the implants at meetings or dinners...
Sorry, you need to subscribe to read this article.
If you would like to access this article, please subscribe below.
Premium subscribers receive complete access to our site content which includes market research and insights as well as coverage of the most important news, issues and events related to the healthcare technology industry.